16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25766632	31	Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2).	Westf£Lische Wilhelms-Universit£T M£Nster
20627722	89	Identification of a sulfonamide series of CCR2 antagonists.	Glaxosmithkline
23079519	86	In vivo activity of an azole series of CCR2 antagonists.	Glaxosmithkline
24900425	72	Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate.	TBA
22608963	109	The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.	Astrazeneca
24900280	81	Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.	TBA
22475558	82	Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone.	Bristol-Myers Squibb
24900329	49	Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.	TBA
21341682	37	Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function.	Telik
21295478	81	Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist.	Incyte
21036044	43	Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.	Incyte
17929797	34	Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.	Johnson & Johnson Pharmaceutical Research and Development
17482462	60	3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.	Merck Research Laboratories
17461566	11	Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.	Merck Research Laboratories
17092717	59	Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.	Merck Research Laboratories